You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,889,138


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,889,138
Title:Method for treating cancer
Abstract: The present invention provides a method for treating or alleviating a symptom of a disorder, e.g., immune evasion, cancer-cell induced immune dysfunction, reduced immune response, lowered inflammation, decreased expression of a major histocompatibility complex (MHC), or cancer, characterized by aberrant, misregulated, or increased Enhancer of Zeste Homolog 2 (EZH2) activity in a cell or subject in need thereof by contacting the cell or administering to the subject a therapeutically effective amount of an EZH2 inhibitor.
Inventor(s): Keilhack; Heike (Belmont, MA)
Assignee: Epizyme, Inc. (Cambridge, MA)
Application Number:15/211,792
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,889,138: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 9,889,138, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

United States Patent 9,889,138, titled "Method for Treating Cancer," is a significant patent in the field of oncology. Here is a brief overview:

  • Publication Number: US9889138B2
  • Authority: United States
  • Prior Art Date: The patent builds upon previous research and inventions related to cancer treatment[4].

Claims of the Patent

The claims of a patent define the scope of the invention and what is protected by the patent. Here are the key aspects of the claims in US9889138B2:

Independent Claims

Independent claims are the broadest claims in a patent and define the core invention. For US9889138B2, these claims typically involve methods for treating cancer, including specific steps and components such as:

  • The use of particular compounds or inhibitors to target cancer cells.
  • Specific dosages and administration methods.
  • The combination of different therapeutic agents to enhance treatment efficacy[4].

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These might include:

  • Specific types of cancer being treated (e.g., breast cancer, lung cancer).
  • Particular patient populations (e.g., patients with a certain genetic marker).
  • Detailed descriptions of the chemical structures of the compounds used[4].

Scope of the Patent

The scope of a patent determines what is protected and what is not. Here are some key points regarding the scope of US9889138B2:

Protected Subject Matter

The patent protects specific methods for treating cancer using defined compounds and therapeutic approaches. This includes:

  • The use of inhibitors to target immune evasion mechanisms in cancer cells.
  • The combination of these inhibitors with other treatments to enhance efficacy[4].

Exclusions and Limitations

The scope also includes what is not protected. For example:

  • Methods that do not use the specific compounds or inhibitors described.
  • Treatments that target different diseases or conditions.
  • Variations in the method that fall outside the described claims[4].

Patent Landscape

Understanding the broader patent landscape is essential to place US9889138B2 in context.

Related Patents

There are numerous patents related to cancer treatment, each with its own unique claims and scope. For instance:

  • Patents focusing on different types of cancer treatments, such as immunotherapy or targeted therapies.
  • Patents covering various compounds and inhibitors used in cancer treatment[1][4].

Global Dossier and International Patents

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding how US9889138B2 fits into the global patent landscape[1].

Search Tools and Resources

Utilizing tools like the Patent Public Search, European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE can help in identifying similar patents and understanding the broader landscape[1].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO can offer insights into the economic and research implications of patents like US9889138B2. This dataset includes detailed information on claims from U.S. patents and patent applications, which can be used to analyze trends and scope measurements[3].

Legal and Policy Considerations

The legal and policy environment surrounding patents is complex. For instance, the study on a potential small claims patent court by the Administrative Conference of the United States (ACUS) highlights the need for streamlined processes for resolving patent disputes, which could impact the enforcement and validity of patents like US9889138B2[2].

Practical Applications and Future Directions

Understanding the practical applications of US9889138B2 involves looking at how the patented methods are being used in clinical settings and research. This includes:

  • Clinical trials and studies that validate the efficacy of the methods described.
  • Future research directions that build upon the patented inventions[4].

Key Takeaways

  • Claims and Scope: The patent protects specific methods for treating cancer using defined compounds and therapeutic approaches.
  • Patent Landscape: Understanding related patents and international filings is crucial for navigating the broader IP landscape.
  • Search Tools: Utilizing resources like the Patent Public Search and Global Dossier can help in identifying similar patents.
  • Economic and Research Implications: The Patent Claims Research Dataset provides valuable insights into patent trends and scope measurements.
  • Legal and Policy Considerations: The legal environment, including potential small claims patent courts, can impact patent enforcement and validity.

FAQs

What is the main focus of United States Patent 9,889,138?

The main focus of US9889138B2 is on methods for treating cancer using specific compounds and inhibitors to target immune evasion mechanisms in cancer cells.

How do I search for related patents?

You can use tools like the Patent Public Search, European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE to search for related patents.

What is the Global Dossier service?

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices.

What is the significance of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and patent applications, which can be used to analyze trends and scope measurements.

How might a small claims patent court impact patents like US9889138B2?

A small claims patent court could streamline the process for resolving patent disputes, potentially affecting the enforcement and validity of patents like US9889138B2.

Sources

  1. USPTO: Search for patents - USPTO
  2. ACUS: U.S. Patent Small Claims Court
  3. USPTO: Patent Claims Research Dataset
  4. Google Patents: US9889138B2 - Method for treating cancer - Google Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,889,138

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING EPITHELIOID SARCOMA ⤷  Subscribe
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA POSITIVE FOR AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MUTATION ⤷  Subscribe
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,889,138

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015331729 ⤷  Subscribe
Australia 2021200995 ⤷  Subscribe
Australia 2022221580 ⤷  Subscribe
Brazil 112017007738 ⤷  Subscribe
Canada 2963149 ⤷  Subscribe
China 106794177 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.